Bausch + Lomb and CROMA fight blindness in Africa
Monday, January 28 2013 | 00 h 00 min | News
Light for the World, the Austrian organization that helps people who have no access to basic eye care, has received support in its fight against cataracts in Africa.
Bausch + Lomb and Croma Pharma donated 50,000 YelloxTM (bromfenac sodium sesquihydrate) eye drops, a non-steroidal anti-inflammatory drug that is essential for postoperative treatment of cataract extraction.
The eye drops only have to be used twice a day, which makes the after-treatment much easier in countries where medical care is hard to get, according to Dr. Karl Rigal, board member of Light for the World. “This is of real benefit to patients in developing countries,” he says.
“Proper post-operative care is the key to maximizing the surgery’s results – ultimately achieving the best possible outcome for the patient,” says Dr. Calvin Roberts, executive vice president and chief medical officer, Bausch + Lomb.
The president and CEO of Croma, Gerhard Prinz, says that “it is our social responsibility and commitment to support the improvement of vision in economically challenged regions of the world.”
Source:
